Synageva BioPharma Corp (NASDAQ:GEVA)

215.79
Delayed Data
As of May 21
 +2.39 / +1.12%
Today’s Change
60.19
Today|||52-Week Range
216.90
+132.56%
Year-to-Date

Today’s Trading

Previous close213.40
Today’s open213.71
Day’s range212.71 - 215.99
Volume878,345
Average volume (3 months)736,064
Market cap$7.9B
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-25.49%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book15.05

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+7.23+4.36%
XONIntrexon Corp+0.47+1.13%
JUNOJuno Therapeutics In...+0.46+1.00%
CTLTCatalent Inc+0.05+0.16%
Data as of 05/21/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$1.79
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers